Pfizer says its experimental pill reduces risk of hospitalization, death from COVID-19
Pfizer says its experimental pill reduces risk of hospitalization, death from COVID-19

Pfizer’s experimental pill to treat COVID-19 is almost 90% effective - that’s according to an interim analysis.

The drug company says its clinical trials were so successful, medical experts recommended stopping the studies early.